US FDA to hold public meeting on pre-market notification process
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration plans to hold a public meeting to discuss key challenges regarding the pre-market notification, or 510(k), procedure used to review and clear certain medical devices1. The meeting is scheduled for 18 February.